Previous 10 | Next 10 |
Sandusky, Ohio--(Newsfile Corp. - January 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the upcoming update covering the company's 2021 cannabis pharmaceutical and nutraceutical development outlook scheduled for tomorrow, Thursday Jan 14 th , 2021, will include an update on the ...
Sandusky, Ohio--(Newsfile Corp. - January 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed an update covering the company's 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14 th , 2021. In 2020, PAOG acquired a hemp cultivation bus...
Sandusky, Ohio--(Newsfile Corp. - January 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update covering the company's 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14 th , 2020. In 2020, PAOG acquired a hemp cultivation bu...
Sandusky, Ohio--(Newsfile Corp. - January 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed that the Company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. ...
Sandusky, Ohio--(Newsfile Corp. - December 22, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced that the company expects to realize and report in Q3 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puratio...
Sandusky, Ohio--(Newsfile Corp. - December 18, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to generate its first revenue next year in 2021 from its Cannabidiol (CBD) extraction technology, RespRx, acquired in July of this year, 2020. Yesterday, PAOG announced ...
Sandusky, Ohio--(Newsfile Corp. - December 17, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an engagement with the Puerto Rico Consortium for Clinical Investigation to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care...
PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval PR Newswire SANDUSKY, Ohio, Oct. 23, 2020 SANDUSKY, Ohio , Oct. 23, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced executing a master s...
PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research PR Newswire SANDUSKY, Ohio, Oct. 20, 2020 SANDUSKY, Ohio , Oct. 20, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted an article just released from Life Sciences: ...
PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday PR Newswire SANDUSKY, Ohio, Oct. 20, 2020 SANDUSKY, Ohio , Oct. 20, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced the company plans to relea...
News, Short Squeeze, Breakout and More Instantly...
PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights PR Newswire SANDUSKY, Ohio , May 6, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout ...
Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under devel...
Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment ...